Oracle Requests your Participation in Survey on Decentralized Clinical Trials

Craig Morgan
Head of Marketing, Study Startup

Decentralized clinical trials (DCTs), deploy a wide range of digital technologies to collect safety and efficacy data from study participants, normally from the comfort of the patients’ own homes.

Oracle Health Sciences is contacting pharmaceutical professionals such as yourself about how organizations are approaching the adoption of decentralized clinical trials and the potential impact of decentralized clinical trials on sponsors and vendors conducting the clinical research.

This confidential survey will take approximately 15 minutes to complete. Importantly, all of your responses will be confidential. Neither your name nor your organization's name will be associated with any of the information or opinions that you provide; however, your responses may be used anonymously in a report that will be developed based on this research.

After completion of the survey you may request an executive summary of key findings from this research.

Thank you for your participation.

Research conducted with support from The Avoca Group.

The Avoca Group

Be the first to comment

Comments ( 0 )
Please enter your name.Please provide a valid email address.Please enter a comment.CAPTCHA challenge response provided was incorrect. Please try again.